Literature DB >> 36213185

Synthesis of (+)-ribostamycin by catalytic, enantioselective hydroamination of benzene.

Chad N Ungarean1, Petra Galer1, Yu Zhang2, Ken S Lee1, Justin M Ngai1, Sungjong Lee1, Peng Liu2, David Sarlah1.   

Abstract

Aminoglycosides (AGs) represent a large group of pseudoglycoside natural products, in which several different sugar moieties are harnessed to an aminocyclitol core. AGs constitute a major class of antibiotics that target the prokaryotic ribosome of many problematic pathogens. Hundreds of AGs have been isolated to date, with 1,3-diaminocyclohexanetriol, known as 2-deoxystreptamine (2-DOS), being the most abundant aglycon core. However, owning to their diverse and complex architecture, all AG-based drugs are either natural substances or analogues prepared by late-stage modifications. Synthetic approaches to AGs are rare and lengthy; most studies involve semi-synthetic reunion of modified fragments. Here we report a bottom-up chemical synthesis of the 2-DOS-based AG antibiotic ribostamycin, which proceeds in ten linear operations from benzene. A key enabling transformation involves a Cu-catalyzed, enantioselective, dearomative hydroamination, which set the stage for the rapid and selective introduction of the remaining 2-DOS heteroatom functionality. This work demonstrates how the combination of a tailored, dearomative logic and strategic use of subsequent olefin functionalizations can provide practical and concise access to the AG class of compounds.

Entities:  

Year:  2022        PMID: 36213185      PMCID: PMC9536474          DOI: 10.1038/s44160-022-00080-x

Source DB:  PubMed          Journal:  Nat Synth        ISSN: 2731-0582


  23 in total

Review 1.  2-Deoxystreptamine: central scaffold of aminoglycoside antibiotics.

Authors:  Guuske F Busscher; Floris P J T Rutjes; Floris L van Delft
Journal:  Chem Rev       Date:  2005-03       Impact factor: 60.622

Review 2.  Molecular insights into aminoglycoside action and resistance.

Authors:  Sophie Magnet; John S Blanchard
Journal:  Chem Rev       Date:  2005-02       Impact factor: 60.622

3.  Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic.

Authors:  M J Weinstein; J A Marquez; R T Testa; G H Wagman; E M Oden; J A Waitz
Journal:  J Antibiot (Tokyo)       Date:  1970-11       Impact factor: 2.649

Review 4.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

5.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

6.  Scalable Synthesis of Anomerically Pure Orthogonal-Protected GlcN3 and GalN3 from d-Glucosamine.

Authors:  Emil Glibstrup; Christian Marcus Pedersen
Journal:  Org Lett       Date:  2016-08-23       Impact factor: 6.005

Review 7.  Dearomatization strategies in the synthesis of complex natural products.

Authors:  Stéphane P Roche; John A Porco
Journal:  Angew Chem Int Ed Engl       Date:  2011-04-19       Impact factor: 15.336

8.  Synthesis of a library of stereo- and regiochemically diverse aminoglycoside derivatives.

Authors:  Blandine Clique; Alan Ironmonger; Benjamin Whittaker; Jacqueline Colley; James Titchmarsh; Peter Stockley; Adam Nelson
Journal:  Org Biomol Chem       Date:  2005-06-23       Impact factor: 3.876

9.  Dearomative dihydroxylation with arenophiles.

Authors:  Emma H Southgate; Jola Pospech; Junkai Fu; Daniel R Holycross; David Sarlah
Journal:  Nat Chem       Date:  2016-08-22       Impact factor: 24.427

Review 10.  Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin.

Authors:  Jacinda C Abdul-Mutakabbir; Razieh Kebriaei; Sarah C J Jorgensen; Michael J Rybak
Journal:  Infect Dis Ther       Date:  2019-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.